Cargando…

Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is a highly aggressive tumor with a poor prognosis and limited treatment options. Finding new approaches to improve TNBC outcomes and response to treatment is critical. Using the 4T1 murine TNBC model, we show the effect of neoadjuvant chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bawaneh, Alaa, Wilson, Adam S., Levi, Nicole, Howard-McNatt, Marissa M., Chiba, Akiko, Soto-Pantoja, David R., Cook, Katherine L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563306/ https://www.ncbi.nlm.nih.gov/pubmed/36230772 http://dx.doi.org/10.3390/cancers14194849

Ejemplares similares

SAT636 Obesity And Aging Interactions Modify The Breast Tissue Microbiome Influencing Cancer Risk
por: Iyengar, Neil M, et al.
Publicado: (2023)

Diet impacts triple‐negative breast cancer growth, metastatic potential, chemotherapy responsiveness, and doxorubicin‐mediated cardiac dysfunction
por: Ramirez, Manuel U., et al.
Publicado: (2022)

Addressing noncommunicable diseases among urban refugees in the Middle East and North Africa - a scoping review
por: McNatt, Zahirah Z.
Publicado: (2020)

Impact of gut permeability on the breast microbiome using a non-human primate model
por: Bawaneh, Alaa, et al.
Publicado: (2022)

Vpu Binds Directly to Tetherin and Displaces It from Nascent Virions
por: McNatt, Matthew W., et al.
Publicado: (2013)

Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer
por: Chougule, Mahavir B., et al.
Publicado: (2011)

Mesenchymal Stem Cell-Induced Doxorubicin Resistance in Triple Negative Breast Cancer
por: Chen, Dar-Ren, et al.
Publicado: (2014)

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
por: Berry, Jameson T.L., et al.
Publicado: (2020)

IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
por: Hum, Nicholas R., et al.
Publicado: (2022)

Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin
por: Krausz, Aimee E., et al.
Publicado: (2018)

Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin
por: Inao, Touko, et al.
Publicado: (2018)

Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo
por: Lothstein, Leonard, et al.
Publicado: (2020)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
por: Martin, Miguel, et al.
Publicado: (2021)

Folate-Functionalized DNA Origami for Targeted Delivery of Doxorubicin to Triple-Negative Breast Cancer
por: Pal, Suchetan, et al.
Publicado: (2021)

High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
por: Torres-Ruiz, Sandra, et al.
Publicado: (2023)

ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy
por: Zhou, Jingyi, et al.
Publicado: (2023)

Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer
por: Zeng, Weiwei, et al.
Publicado: (2023)

Changing hospital organisational culture for improved patient outcomes: developing and implementing the leadership saves lives intervention
por: Linnander, Erika, et al.
Publicado: (2021)

Associations between physical activity, sleep, and self-reported health with burnout of medical students, faculty and staff in an academic health center
por: Howie, Erin K., et al.
Publicado: (2022)

Laparoscopic-Assisted Transgastric ERCP: A Single-Institution Experience
por: Habenicht Yancey, Katherine, et al.
Publicado: (2018)

A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer
por: McKenna, Matthew T., et al.
Publicado: (2017)

Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
por: Salerno, Dominick, et al.
Publicado: (2021)

The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells
por: Mentoor, Ilze, et al.
Publicado: (2021)

Cytoprotective Effect of Vitamin D on Doxorubicin-Induced Cardiac Toxicity in Triple Negative Breast Cancer
por: Lee, Kevin J, et al.
Publicado: (2021)

Pharmacometabolomics reveals urinary diacetylspermine as a biomarker of doxorubicin effectiveness in triple negative breast cancer
por: Velenosi, Thomas J., et al.
Publicado: (2022)

Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro
por: Garza-Morales, Rodolfo, et al.
Publicado: (2018)

A national system for monitoring the performance of hospitals in Ethiopia
por: McNatt, Zahirah, et al.
Publicado: (2015)

TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel
por: Wardhani, Bantari WK, et al.
Publicado: (2020)

Understanding doxorubicin associated calcium remodeling during triple-negative breast cancer treatment: an in silico study
por: Arora, Garhima, et al.
Publicado: (2021)

Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
por: Dong, Hang, et al.
Publicado: (2023)

Comparative Evaluation of the Cytotoxicity of Doxorubicin in BT-20 Triple-Negative Breast Carcinoma Monolayer and Spheroid Cultures
por: Ncube, Keith N., et al.
Publicado: (2023)

“UPRegulation” of CD47 by the endoplasmic reticulum stress pathway controls anti-tumor immune responses
por: Cook, Katherine L., et al.
Publicado: (2017)

SIV Nef Proteins Recruit the AP-2 Complex to Antagonize Tetherin and Facilitate Virion Release
por: Zhang, Fengwen, et al.
Publicado: (2011)

Implementation of the WHO Surgical Safety Checklist in an Ethiopian Referral Hospital
por: Bashford, Tom, et al.
Publicado: (2014)

Use of a national collaborative to improve hospital quality in a low-income setting
por: Linnander, Erika, et al.
Publicado: (2016)

Exploring the lived experiences of parents caring for infants with gastroschisis in Rwanda: The untold story
por: Kidane, Samuel, et al.
Publicado: (2022)

Understanding and harnessing triple-negative breast cancer-related microbiota in oncology
por: Devoy, Ciaran, et al.
Publicado: (2022)

Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance
por: Robinson, Prema, et al.
Publicado: (2016)

New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells
por: Ciocan-Cartita, Cristina Alexandra, et al.
Publicado: (2020)

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_coaro5g8f24pnetcthr5ofv6v7